1) My gut feeling from hearing of Omicron cases in Botswana, ex-Malawi, ex-Egypt (2 now it seems) and in South Africa is, that the variant was flying under the radar in undersequenced countries for some time until Botswana and South Africa detected it and sounded the alarm.
2) However, the fact that European countries only detected it in travelers after South Africa and others warned about it, probably means that many cases so far went undetected. It also tells us a lot about genomic surveillance in some high income countries.
3) The mutations in Omicron which seem to wipe out the majority of neutralizing antibody epitopes are very worrisome. Combined with the apparent fitness of the virus, this could be a problem. There is now a lot to do to get a better idea of the risk this virus variant poses.
4) We need to first figure out how widespread it is, how well it escapes neutralizing antibodies (assumption: very well), what its R0 is, how well it does against Delta and if it can cause severe disease in vaccinated or recovered individuals.
5) Adapted vaccines need to be tested (this has started already) etc. Also, we should not forget that non-neutralizing antibody epitopes and T-cell epitopes are likely largely intact. And even if a variant vaccine becomes necessary, we would not start from scratch....
6).....since it is likely that one 'variant-booster' would do the job. Our B-cells can be retrained to recognize both, the old version and the variant, and it doesn't take much to do that.
7) But there are a lot of unknowns, and many 'scariants' have come and gone. I assume we will have a much better idea about the actual risk in 2-3 weeks. We need to stay calm and do our work.
8) A shoutout and big thank you to @Tuliodna and many other researchers from South Africa and Botswana for sharing sequences and information in real time!
9) There was an update on the second case from Egypt. It seems now it was not from Egypt:

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Florian Krammer

Florian Krammer Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @florian_krammer

20 Nov
@JulyaRabinowich @florianklenk @aufBlende 1) Warum? Weil wir (Wissenschafter, Medien etc.) sie nicht erreichen. Wir kommunizieren nicht gut genug. Wir schliessen sie aus. Deshalb. Aber ich bin Virologe, nicht Kommunikationswissenschafter oder Soziologe, ich weiss nicht wie man das ändern kann.
@JulyaRabinowich @florianklenk @aufBlende 2) Meiner eigenen Erfahrung nach funktionieren nur persönliche Gespräche in einer Atmosphäre wo keiner die Leute auslacht oder lächerlich macht und wo sie alles Fragen können was sie wollen. Das funktioniert aber nicht 'large scale'. Das geht nur von Person zu Person.
@JulyaRabinowich @florianklenk @aufBlende 3) Ich finde es aber persönlich oft auch schwierig, vor allem hier auf Social Media, nicht sarkastisch zu werden. Wir sind alle müde und überfordert und emotional am Ende. Aber man darf nicht vergessen, dies Leute sind meistens Opfer, nicht Täter.
Read 5 tweets
11 Nov
@yousitonmyspot 1) Nach der 2. Impfung kommt es zu einer starken Stimulation des Immunsystems, Antikoerper Titer sind sehr hoch, es passiert viel in den Lymphknoten, langlebige Plasmazellen werden gebildet und migrieren ins Knochenmark. Mittlerweile wissen wir, das der Prozess etwas dauert.
@yousitonmyspot 2) Kollege Ali Ellebedy hat dazu wahnsinnig schoene Daten. Ein längerer Abstand zwischen 2. Impfung und Booster erlaubt dem Immunsystem, den Prozess zu beenden. Und wenn man dann wieder Impft, kriegt man einen maximalen Booster Effekt. 6 Monate sind da ein vernünftiger Interval.
@yousitonmyspot 3) Fuenf Monate sind vermutlich auch kein Problem. Aber 2 oder 3 Monate sind vermutlich suboptimal und es kommt auch ein bissl auf das Individuum darauf an. Aber 6 Monate sind ein guter und effektiver Abstand.
Read 6 tweets
25 Oct
1) We have a new paper out in Nature Communications. "Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus". The WSEIV is an influenza B like virus that seems to infect fish, spiny eels. nature.com/articles/s4146…
2) The virus sequence was discovered by @edwardcholmes and colleagues among many other RNA virus sequences from fish and amphibians (nature.com/articles/s4158…). We then characterized the HA and NA of the virus. Turns out, the NA is a bona fide neuraminidase that can be inhibited...
3) ....by oseltamivir and the fantastic pan-NA mAbs 1G01 (science.org/doi/10.1126/sc…). The HA however binds very specifically to GM2, a ganglioside. This may open up using this HA to target specific cancer cells (as oncolytic) or brain cells (for gene therapy).
Read 5 tweets
6 Oct
1) For people worried about H5N6: Zoonotic infections with influenza viruses happen all the time. They may lead to severe disease and death in exposed individuals but as long as there is no human to human transmission....
2)....there is little to worry from a global perspective. Of course we need to keep an eye on them and prepare prototype vaccines (which is something that has been done for many of these viruses). Here is a slide that shows how often these zoonotic infections are found. It is....
3)....a little outdated, but I think you get the idea - it happens often. Purple are viruses with associated human cases, blue are viruses that should be watched because they caused remarkable outbreaks in animals. H2N2 is in red because it has caused a pandemic in the past....
Read 4 tweets
15 Sep
@MRoscus @EricTopol 1) So, here is the issue: Changing the vaccine strain is technically easy. From a regulatory and from a roll-out perspective not so much. Now, it will take time. And this was attempted for B.1.351.
@MRoscus @EricTopol 2) Moderna did a booster study with an updated version of the vaccine that expressed the B.1.351 and compared that to the original version of the vaccine as a booster dose. Now here are the results: medrxiv.org/content/10.110…
@MRoscus @EricTopol 3) The B.1.351 booster induced antibodies a little (not even 2-fold) better than the original vaccine when looking at B.1.351 virus neutralization. No benefit against another variant (P.1) which is closely related to B.1.351.
Read 8 tweets
14 May
1) @Guha_Arunkumar is defending today! I am so excited! Will he tell us about the weird fish viruses that look like influenza B? Or his work on influenza B antigenicity and mAbs? Thanks @jbloom_lab for being the outside examiner.
2) Also, Guha is interested in getting an industry job somewhere on the East Coast. If you are looking for a competent infectious disease researcher/virologist/biotechnologist better contact him quickly!
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(